Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0005203947
Thu, 25.05.2023
BRAIN Biotech AG
BRAIN Biotech AG stays on solid growth path with H1 results and accelerates One-BioProducts strategy
H1 ‘22/23 growth +16.8%, +8.2% organic
Cash position a solid € 9.2 million
Full ownership of core asset Biocatalysts Ltd achieved
Zwingenberg, Germany, May 25th, 2023 – BRAIN Biotech AG, a leading provider of integrated solutions for the biologi [ … ]
Thu, 25.05.2023
BRAIN Biotech AG
BRAIN Biotech AG stays on solid growth path with H1 results and accelerates One-BioProducts strategy
H1 ‘22/23 growth +16.8%, +8.2% organic
Cash position a solid € 9.2 million
Full ownership of core asset Biocatalysts Ltd achieved
Zwingenberg, Germany, May 25th, 2023 – BRAIN Biotech AG, a leading provider of integrated solutions for the biologi [ … ]
Wed, 24.05.2023
BRAIN Biotech AG
BRAIN Biotech AG gains full ownership of Biocatalysts Ltd and accelerates execution of its One-BioProducts Strategy
BRAIN Biotech bought the two remaining minority stakes in Biocatalysts Ltd
Transaction financed from existing cash and from new debt
All industrial products businesses will now be merged under Biocatalysts’ leadership
Zwingenberg ( [ … ]
Wed, 24.05.2023
BRAIN Biotech AG
BRAIN Biotech AG gains full ownership of Biocatalysts Ltd and accelerates execution of its One-BioProducts Strategy
BRAIN Biotech bought the two remaining minority stakes in Biocatalysts Ltd
Transaction financed from existing cash and from new debt
All industrial products businesses will now be merged under Biocatalysts’ leadership
Zwingenberg ( [ … ]
Wed, 08.03.2023
BRAIN Biotech AG
Resolutions of the Annual General Meeting 2023 on the Financial Year 2021/2022 of BRAIN Biotech AG
Executive Board and Supervisory Board discharged with large majority
Large majorities in the re-election of one member to the Supervisory Board and the election of two new members
New compensation system for Executive Board approved
Zwingenberg (Ge [ … ]
Wed, 08.03.2023
BRAIN Biotech AG
Resolutions of the Annual General Meeting 2023 on the Financial Year 2021/2022 of BRAIN Biotech AG
Executive Board and Supervisory Board discharged with large majority
Large majorities in the re-election of one member to the Supervisory Board and the election of two new members
New compensation system for Executive Board approved
Zwingenberg (Ge [ … ]
Mon, 27.02.2023
BRAIN Biotech AG
Capital Markets Day 2023: BRAIN Biotech AG to build an international multi-niche enzyme and food ingredients champion
Strategy: building a successful international multi-niche enzyme and food ingredients champion
Performance made visible: new organizational setup
Incubator: Akribion Genomics to focus on opportunities in therapeutics
Upgraded ne [ … ]
Mon, 27.02.2023
BRAIN Biotech AG
Capital Markets Day 2023: BRAIN Biotech AG to build an international multi-niche enzyme and food ingredients champion
Strategy: building a successful international multi-niche enzyme and food ingredients champion
Performance made visible: new organizational setup
Incubator: Akribion Genomics to focus on opportunities in therapeutics
Upgraded ne [ … ]
Mon, 27.02.2023
BRAIN Biotech AG
BRAIN Biotech AG with Strong Start into Fiscal Year 2022/23, 3M Reporting
Total group revenues plus 35%, organic plus 19%
Both segments contribute with double digit organic growth
Cash on-hand improved
Zwingenberg, Germany, 27. February 2023 – BRAIN Biotech AG, a leading provider of integrated solutions for the biologization of industry, had a s [ … ]
Mon, 27.02.2023
BRAIN Biotech AG
BRAIN Biotech AG with Strong Start into Fiscal Year 2022/23, 3M Reporting
Total group revenues plus 35%, organic plus 19%
Both segments contribute with double digit organic growth
Cash on-hand improved
Zwingenberg, Germany, 27. February 2023 – BRAIN Biotech AG, a leading provider of integrated solutions for the biologization of industry, had a s [ … ]